Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
1001
Biotest Pharma GmbH
Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)
1 trial -
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine
Arcturus Therapeutics Holdings
COVID-19 Vaccines
1 trial -
ARCT-2303
Arcturus Therapeutics Holdings
COVID-19
1 trial -
Adsorbed COVID-19 (inactivated) Vaccine
Sinovac Research and Development Co.,
COVID-19
1 trial -
C5091017
Pfizer Australia Pty Ltd
Covid-19 at high risk of progression to severe illness.
1 trial -
C5091018
Pfizer Australia Pty Ltd
Coronavirus Disease 2019 (COVID-19)
1 trial -
CARDIOL 100-03
Cardiol Therapeutics
COVID-19
1 trial -
CNBG-BIBP-O-2022003
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
2 trials -
COVID-19 Vaccine,Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
CPI-006 2 mg/kg + SOC
Corvus Pharmaceuticals
Covid-19
1 trial -
Ceftriaxone
Adaptive Biotechnologies Corp
Community-acquired Pneumonia, Influenza, COVID-19
1 trial -
Cetirizine
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
D7000C00001
AstraZeneca AB
COVID-19
1 trial -
Dociparstat sodium
Jazz Pharmaceuticals Ireland Limited
Coronavirus Disease 2019 (COVID-19)
1 trial -
GS-5245 tablets 175 mg, GS-5245 tablets 350 mg
Gilead Sciences Pty Limited
COVID-19
1 trial -
Inactivated COVID-19 Vaccine
Sinovac Research and Development Co.,
COVID-19
4 trials -
Losmapimod oral tablet
Fulcrum Therapeutics
COVID-19
1 trial -
MK-4482-023
Merck Sharp and Dohme
SARS-CoV-2 (COVID-19) infection
1 trial -
Medium-dosage COVID-19 Vaccine,Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Molnupiravir
Merck KGaA, Darmstadt, Germany
Coronavirus Disease (COVID-19)
2 trials -
Opaganib
RedHill Biopharma
COVID-19
2 trials -
PF-07321332
Pfizer
COVID-19
2 trials -
PRO-onCOV-3001
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-tnCOV-3003
Sinovac Research and Development Co.,
COVID-19
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.